<DOC>
	<DOCNO>NCT02375867</DOCNO>
	<brief_summary>Fulminant hepatic failure ( FHF ) child potentially devastate disease . The mortality rate may reach 80-90 % absence liver transplantation . Liver injury consider mainly immune mediate augmentation cytolytic pathway infect hepatocytes . For , suggest corticosteroid modulate activity disease suppress immune system .</brief_summary>
	<brief_title>Steroids Fulminant Hepatic Failure Pediatric Age Group</brief_title>
	<detailed_description>Fulminant hepatic failure ( FHF ) child potentially devastate disease . The mortality rate may reach 80-90 % absence liver transplantation . FHF clinical manifestation liver cell death critical degree insufficient hepatocellular regeneration characterize coagulopathy without hepatic encephalopathy . Liver injury consider mainly immune mediate augmentation cytolytic pathway infect hepatocytes . For , suggest corticosteroid modulate activity disease suppress immune system .</detailed_description>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>The patient diagnose FHF , fulfil follow criterion : 1 . Evidence liver dysfunction within 8 week onset symptom ( neonate may derange liver function without overt symptom ) . 2 . Uncorrectable coagulopathy ( 68 hour administration one dose parenteral vitamin K ) International Normalized Ratio ( INR ) &gt; 1.5 patient hepatic encephalopathy , INR &gt; 2.0 patient without encephalopathy . 3 . No evidence chronic liver disease . 1 . Presence absolute contraindication steroid therapy ( presence active gastrointestinal bleeding , renal failure , acute pancreatitis , active tuberculosis , uncontrolled diabetes psychosis ) . 2 . Presence absolute contraindication growth hormone therapy ( active malignancy , benign intracranial hypertension , proliferative preproliferative diabetic retinopathy )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>